Cyanofluoropyrrolidine derivative

Details for Australian Patent Application No. 2004238719 (hide)

Owner Taisho Pharmaceutical Co., Ltd.

Inventors Takahashi, Masato; Mikami, Ayako; Fukushima, Hiroshi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004238719

PCT Pub. Number WO2004/101514

Priority 2003-137062 15.05.03 JP

Filing date 17 May 2004

Wipo publication date 25 November 2004

International Classifications

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

A61K 31/4439 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/433 (2006.01) - Thiadiazoles

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61K 31/454 (2006.01)

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2004/101514 Priority application(s): WO2004/101514

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238745-Combination of a dispenser and container for carbonated drink

2004238713-Oligopeptide